Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

852 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial.
Li X, Bilcke J, van der Velden AW, Bongard E, Bruyndonckx R, Sundvall PD, Harbin NJ, Coenen S, Francis N, Bruno P, Garcia-Sangenis A, Glinz D, Kosiek K, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Tsakountakis N, Aabenhus R, Butler CC, Beutels P. Li X, et al. Among authors: seifert b. Clin Drug Investig. 2021 Aug;41(8):685-699. doi: 10.1007/s40261-021-01057-y. Epub 2021 Jul 22. Clin Drug Investig. 2021. PMID: 34292510 Free PMC article. Clinical Trial.
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.
Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, Francis NA, Lewis RJ, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Seifert B, Sundvall PD, Colliers A, Aabenhus R, Bjerrum L, Jonassen Harbin N, Lindbæk M, Glinz D, Bucher HC, Kovács B, Radzeviciene Jurgute R, Touboul Lundgren P, Little P, Murphy AW, De Sutter A, Openshaw P, de Jong MD, Connor JT, Matheeussen V, Ieven M, Goossens H, Verheij TJ. Butler CC, et al. Among authors: seifert b. Lancet. 2020 Jan 4;395(10217):42-52. doi: 10.1016/S0140-6736(19)32982-4. Epub 2019 Dec 12. Lancet. 2020. PMID: 31839279 Clinical Trial.
Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries.
Ouchi D, García-Sangenís A, Moragas A, van der Velden AW, Verheij TJ, Butler CC, Bongard E, Coenen S, Cook J, Francis NA, Godycki-Cwirko M, Lundgren PT, Lionis C, Radzeviciene Jurgute R, Chlabicz S, De Sutter A, Bucher HC, Seifert B, Kovács B, de Paor M, Sundvall PD, Aabenhus R, Harbin NJ, Ieven G, Goossens H, Lindbæk M, Bjerrum L, Llor C. Ouchi D, et al. Among authors: seifert b. Fam Pract. 2022 May 28;39(3):398-405. doi: 10.1093/fampra/cmab122. Fam Pract. 2022. PMID: 34611715 Clinical Trial.
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data.
Verheij TJ, Cianci D, van der Velden AW, Butler CC, Bongard E, Coenen S, Colliers A, Francis NA, Little P, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Sundvall PD, Bjerrum L, De Sutter A, Aabenhus R, Harbin NJ, Lindbæk M, Glinz D, Bucher HC, Kovács B, Seifert B, Jurgute RR, Lundgren PT, de Paor M, Matheeussen V, Goossens H, Ieven M. Verheij TJ, et al. Among authors: seifert b. Br J Gen Pract. 2022 Feb 24;72(716):e217-e224. doi: 10.3399/BJGP.2021.0344. Print 2022 Mar. Br J Gen Pract. 2022. PMID: 34990385 Free PMC article. Clinical Trial.
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
Li X, Bilcke J, van der Velden AW, Bruyndonckx R, Coenen S, Bongard E, de Paor M, Chlabicz S, Godycki-Cwirko M, Francis N, Aabenhus R, Bucher HC, Colliers A, De Sutter A, Garcia-Sangenis A, Glinz D, Harbin NJ, Kosiek K, Lindbæk M, Lionis C, Llor C, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Sundvall PD, Touboul Lundgren P, Tsakountakis N, Verheij TJ, Goossens H, Butler CC, Beutels P; ALIC4Etrial investigators. Li X, et al. Among authors: seifert b. Eur J Health Econ. 2023 Aug;24(6):909-922. doi: 10.1007/s10198-022-01521-2. Epub 2022 Sep 22. Eur J Health Econ. 2023. PMID: 36131214 Free PMC article.
High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care Settings.
Lionis C, Anastasaki M, Bertsias A, Angelaki A, Carlsson AC, Gudjonsdottir H, Wändell P, Larrabee Sonderlund A, Thilsing T, Søndergaard J, Seifert B, Kral N, De Wit NJ, Hollander M, Korevaar J, Schellevis F. Lionis C, et al. Among authors: seifert b. Int J Environ Res Public Health. 2020 Dec 4;17(23):9080. doi: 10.3390/ijerph17239080. Int J Environ Res Public Health. 2020. PMID: 33291815 Free PMC article.
Unwillingness to participate in health checks for cardiometabolic diseases: A survey among primary health care patients in five European countries.
de Waard AM, Korevaar JC, Hollander M, Nielen MMJ, Seifert B, Carlsson AC, Lionis C, Søndergaard J, Schellevis FG, de Wit NJ; SPIMEU project group. de Waard AM, et al. Among authors: seifert b. Health Sci Rep. 2021 Mar 24;4(2):e256. doi: 10.1002/hsr2.256. eCollection 2021 Jun. Health Sci Rep. 2021. PMID: 33778166 Free PMC article.
What should selective cardiometabolic prevention programmes in European primary care look like? A consensus-based design by the SPIMEU group.
Král N, de Waard AM, Schellevis FG, Korevaar JC, Lionis C, Carlsson AC, Sønderlund AL, Søndergaard J, Larsen LB, Hollander M, Thilsing T, Angelaki A, de Wit NJ, Seifert B. Král N, et al. Among authors: seifert b. Eur J Gen Pract. 2019 Jul;25(3):101-108. doi: 10.1080/13814788.2019.1641195. Epub 2019 Aug 14. Eur J Gen Pract. 2019. PMID: 31411091 Free PMC article.
852 results